All In MedTech

Device Trial Radar · NCT04494295

The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation

Last checked: Nov 19, 2026Latest source record: Feb 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Oct 23, 2020

Primary completion

Oct 15, 2028

Study completion Oct 15, 2029

Sponsor

Lead sponsor
Integra LifeSciences CorporationPublic (IART)
Sponsor type
Industry
Collaborators
Icahn School of Medicine at Mount Sinai; Oculus Imaging LLC
First posted
Jul 31, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This registry will study the use of the Aurora® Surgiscope to provide surgical access and visualization in minimally invasive removal of hematoma in the brain. Many methods of hematoma removal are available and will be based on surgeon preference. The impact of patient selection and time to surgery from last known well time will be explored.

Conditions

  • Supratentorial Hemorrhage

Interventions

  • Aurora Surgiscope SystemDevice

    MIS evacuation of hematoma using the Aurora Surgiscope System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Surgical SuccessTime frame: During surgical procedure to evacuate supratentorial intracerebral hemorrhage

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Providence Health

    Burbank, California · Recruiting

  • University of Miami

    Miami, Florida · Recruiting

  • University of South Florida

    Tampa, Florida · Recruiting

17 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.